MAPK8 and cancer: 4-HPR is a synthetic retinoid with antitumor activity and is known to cause cellular metabolic perturbations and induction of apoptosis in ovarian and other cancer cells via ROS-dependent mechanisms involving ER stress and MAPK (e.g. JNK) activation [18,37].